Publication | Open Access
A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids
15
Citations
24
References
2020
Year
GSK study ID: 205832; Clinicaltrials.gov ID: NCT03012061.
| Year | Citations | |
|---|---|---|
Page 1
Page 1